No takes yet. Share an insight, caveat, or question.
Economic evaluation reveals variable impacts of testing subsidies on infection rates in at-risk populations, suggesting program design critically determines whether subsidies lower disease spread.
Philipson et al. (1995) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: